AJOVY
Active substance: fremanezumab
INJECTION · FREMANEZUMAB 225 mg/1.5mL
United StatesActive
Marketing holder: Teva Pharmaceuticals USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- FREMANEZUMAB · 225 mg/1.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-3ab9-7d4c-ad23-e4fd87ef98f1,01a12096-218d-7d1f-90ff-ddd3ad09f1f7;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 51759-202
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 51759-202 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 51759-202 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 51759-202 · Verified 2026-10-09 · open in source